Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Nephros Inc. (NEPH)

Surgical & Medical Instruments & Apparatus

https://www.nephros.com

Nephros Inc is a commercial-stage company that develops and sells high performance water solutions to the medical and commercial markets. In medical markets, it sell water filtration products and waterborne pathogen detection products. In commercial markets, the company manufacture and sell water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The operating segments of the group are Water Filtration, Pathogen Detection and Renal Products of which key revenue is derived from Water Filtration segment.

380 LACKAWANNA PLACE
SOUTH ORANGE, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/21/2004

Market Cap

19,436,994

Shares Outstanding

10,490,000

Weighted SO

10,484,932

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

POCI --.--%

KRMD --.--%

INFU --.--%

UTMD --.--%

MLSS --.--%

PDEX --.--%

CLPBY --.--%

OPSSF --.--%

Beta

1.1900

Last Div

0.0000

Range

1.35-4.04

Chg

-0.0266

Avg Vol

13893

Mkt Cap

19436994

Exch

NASDAQ

Country

US

Phone

201 343 5202

DCF Diff

0.6942

DCF

1.6942

Div Yield

0.0000

P/S

1.4115

EV Multiple

-15.2785

P/FV

2.4444

Div Yield %

0.0000

P/E

-14.9722

PEG

-1.3933

Payout

-0.0595

Current Ratio

4.0605

Quick Ratio

2.6245

Cash Ratio

1.5779

DSO

49.7800

DIO

183.5477

Op Cycle

233.3277

DPO

75.8943

CCC

157.4333

Gross Margin

0.5952

Op Margin

-0.0994

Pretax Margin

-0.0940

Net Margin

-0.0940

Eff Tax Rate

0.0010

ROA

-0.1166

ROE

-0.1564

ROCE

-0.1497

NI/EBT

1.0000

EBT/EBIT

0.9452

EBIT/Rev

-0.0994

Debt Ratio

0.1423

D/E

0.1993

LT Debt/Cap

0.1336

Total Debt/Cap

0.1662

Int Coverage

-684.5000

CF/Debt

-0.5367

Equity Multi

1.4005

Rec Turnover

7.3323

Pay Turnover

4.8093

Inv Turnover

1.9886

FA Turnover

7.9275

Asset Turnover

1.2405

OCF/Share

-0.0807

FCF/Share

-0.0931

Cash/Share

0.2931

OCF/Sales

-0.0616

FCF/OCF

1.1533

CF Coverage

-0.5367

ST Coverage

-2.3687

CapEx Coverage

-6.5231

Div&CapEx Cov

-4.0966

P/BV

2.4444

P/B

2.4444

P/S

1.4115

P/E

-14.9722

P/FCF

-19.8742

P/OCF

-22.8467

P/CF

-22.8467

PEG

-1.3933

P/S

1.4115

EV Multiple

-15.2785

P/FV

2.4444

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 01, 07:30 Nephros Hires Judy Krandel as Chief Financial Officer GlobeNewswire Inc. Oct 25, 07:30 Nephros Schedules Third Quarter 2023 Financial Results Conference Call

Revenue Product Segmentation